Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Wilmington Business News

Ashland
Regional

Ashland Reports Fourth-Quarter and Fiscal 2025 Results, Issues 2026 Outlook

November 12, 2025November 11, 2025 - by Timothy Alexander

WILMINGTON, DE — Ashland Inc. (NYSE: ASH) reported financial results for the fourth quarter and full fiscal year ended September 30, 2025, while providing guidance for fiscal 2026. The global …

Ashland Reports Fourth-Quarter and Fiscal 2025 Results, Issues 2026 Outlook Read More

Edify Engine
Regional

Delaware Startup Edify Engine Launches ‘WordPress of 3D’ for the Web3 Era

November 12, 2025November 11, 2025 - by Timothy Alexander

WILMINGTON, DE — Edify Engine, a Delaware-based technology company, has officially launched its public platform, giving users the ability to create and publish immersive, interactive 3D worlds through simple AI …

Delaware Startup Edify Engine Launches ‘WordPress of 3D’ for the Web3 Era Read More
Vasco Electronics
Regional

Vasco Electronics Unveils AI-Powered Translator That Mimics Your Voice

November 12, 2025November 11, 2025 - by Timothy Alexander

WILMINGTON, DE — Vasco Electronics has introduced the Vasco Translator Q1, a next-generation language device capable of translating real-time conversations in 113 languages — and now, for the first time, …

Vasco Electronics Unveils AI-Powered Translator That Mimics Your Voice Read More

Prelude Therapeutics
Regional

Prelude Therapeutics Reshapes Pipeline With Incyte Deal and Strategic Refocus

November 11, 2025November 10, 2025 - by Timothy Alexander

WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced a series of strategic updates aimed at sharpening its development priorities and extending its financial runway. The biotechnology company has executed …

Prelude Therapeutics Reshapes Pipeline With Incyte Deal and Strategic Refocus Read More
Prelude Therapeutics
Regional

Prelude Strikes $910 Million Deal With Incyte for Groundbreaking JAK2 Cancer Therapy

November 11, 2025November 10, 2025 - by Timothy Alexander

WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has entered into an exclusive option agreement with Incyte Corporation (Nasdaq: INCY) for its mutant-selective JAK2V617F JH2 inhibitor program, a next-generation therapy …

Prelude Strikes $910 Million Deal With Incyte for Groundbreaking JAK2 Cancer Therapy Read More

Prelude Therapeutics
Regional

Prelude Therapeutics Highlights Groundbreaking Blood Cancer Research at ASH 2025

November 11, 2025November 10, 2025 - by Timothy Alexander

WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced the publication of two abstracts featuring preclinical data from its JAK2V617F mutant-selective inhibitor program and CALR-targeted degrader antibody conjugates (DACs) discovery …

Prelude Therapeutics Highlights Groundbreaking Blood Cancer Research at ASH 2025 Read More
The Bancorp
Regional

The Bancorp Posts Strong Q3, Boosted by Fintech Expansion and Share Buybacks

November 11, 2025November 9, 2025 - by Timothy Alexander

WILMINGTON, DE — The Bancorp, Inc. (NASDAQ: TBBK) reported another solid quarter of growth, driven by strong fintech lending activity, higher transaction volumes, and an aggressive share repurchase strategy.

The Bancorp Posts Strong Q3, Boosted by Fintech Expansion and Share Buybacks Read More

WSFS CARES Foundation
Regional

WSFS CARES Foundation Awards $50,000 Grant to Expand Family Housing Initiative

November 10, 2025November 8, 2025 - by Timothy Alexander

WILMINGTON, DE — The WSFS CARES Foundation, the charitable arm of WSFS Financial Corporation (Nasdaq: WSFS), announced a $50,000 grant to Social Finance, Inc. to support the launch of the …

WSFS CARES Foundation Awards $50,000 Grant to Expand Family Housing Initiative Read More
Global Indemnity Group
Regional

Global Indemnity Sees Strong Third Quarter as Operating Income Climbs 19%

November 10, 2025November 8, 2025 - by Timothy Alexander

WILMINGTON, DE — Global Indemnity Group, LLC (NYSE: GBLI) reported solid third-quarter 2025 financial results, highlighted by a 19% year-over-year increase in operating income and a 54% rise in current …

Global Indemnity Sees Strong Third Quarter as Operating Income Climbs 19% Read More
The Chemours Company
Regional

Chemours Declares Fourth-Quarter Dividend as It Advances Global Growth Strategy

November 10, 2025November 8, 2025 - by Timothy Alexander

WILMINGTON, DE — The Chemours Company (NYSE: CC) announced that its Board of Directors has declared a quarterly cash dividend of $0.0875 per share on the company’s common stock for …

Chemours Declares Fourth-Quarter Dividend as It Advances Global Growth Strategy Read More

Posts pagination

Previous 1 … 55 56 57 … 87 Next

Trending News

  • Free Attire and Reentry Resources at Open Wardrobe FIVE Locations: Including Kennett Square and NEW Malvern!

  • Avon Grove Offers a Quieter, Sensory-Friendly Visit With Santa

  • Unionville-Chadds Ford Advances $164 Million School Project

  • Malvern Wreath Ceremony Honors 52 Fallen Revolutionary Soldiers

  • Ephrata Man Faces Child Sex Abuse Charges, $500K Bail

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

clothing insecurity

Free Attire and Reentry Resources at Open Wardrobe FIVE Locations: Including Kennett Square and NEW Malvern!

November 19, 2026November 18, 2026

Vincenzo Azzarelli

Ephrata Man Faces Child Sex Abuse Charges, $500K Bail

November 18, 2026November 18, 2026

suspect

$534 Retail Theft Prompts Police Appeal in Wyomissing

November 18, 2026November 18, 2026

Copyright © 2026 MyChesCo.